Speaking of the $$ from China to underwrite the clinical trials, if GNBT were to offer warrants to current NGIO shareholders at, say, 5.00, with a promise to reward me with an equal number of shares in NGIO at market value on July 1, i’d definitely steP up. That’s how much faith I have in their long term prospects. And...I’m willing to absorb some risk to avoid the prospect of the company going ‘outside’ to raise $$ for the clinical trials from vultures. Let current shareholders share in both the risk AND the rewards.